Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 25;25(11):5749.
doi: 10.3390/ijms25115749.

The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders

Affiliations
Review

The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders

Anna Stasiłowicz-Krzemień et al. Int J Mol Sci. .

Abstract

Neurological disorders present a wide range of symptoms and challenges in diagnosis and treatment. Cannabis sativa, with its diverse chemical composition, offers potential therapeutic benefits due to its anticonvulsive, analgesic, anti-inflammatory, and neuroprotective properties. Beyond cannabinoids, cannabis contains terpenes and polyphenols, which synergistically enhance its pharmacological effects. Various administration routes, including vaporization, oral ingestion, sublingual, and rectal, provide flexibility in treatment delivery. This review shows the therapeutic efficacy of cannabis in managing neurological disorders such as epilepsy, neurodegenerative diseases, neurodevelopmental disorders, psychiatric disorders, and painful pathologies. Drawing from surveys, patient studies, and clinical trials, it highlights the potential of cannabis in alleviating symptoms, slowing disease progression, and improving overall quality of life for patients. Understanding the diverse therapeutic mechanisms of cannabis can open up possibilities for using this plant for individual patient needs.

Keywords: Cannabis sativa; cannabidiol; cannabis; neurological disorders; tetrahydrocannabinol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
The structures of cannabinoids (cannabidiol and Δ9-tetrahydrocannabinol) in neutral, acidic, and varinic forms.
Figure 2
Figure 2
Chemical structures of chosen terpenes, myrcene, limonene, α-pinene, and linalool.
Figure 3
Figure 3
Chemical structures of cannflavins.
Figure 4
Figure 4
The potential of cannabis use in discussed neurological diseases of various etiologies.
Figure 5
Figure 5
The possible mechanisms of action of CBD in epilepsy [105].

Similar articles

Cited by

References

    1. Sarfo F.S., Akassi J., Badu E., Okorozo A., Ovbiagele B., Akpalu A. Profile of Neurological Disorders in an Adult Neurology Clinic in Kumasi, Ghana. eNeurologicalSci. 2016;3:69–74. doi: 10.1016/j.ensci.2016.03.003. - DOI - PMC - PubMed
    1. Carriba P., Lorenzón N., Dierssen M. Neurodevelopmental Disorders: 2023 Update. Free Neuropathol. 2023;4:4–8. doi: 10.17879/freeneuropathology-2023-4701. - DOI - PMC - PubMed
    1. Crary J.F. Neurodegeneration: 2023 Update. Free Neuropathol. 2023;4:4–13. doi: 10.17879/freeneuropathology-2023-4899. - DOI - PMC - PubMed
    1. Lamptey R.N.L., Chaulagain B., Trivedi R., Gothwal A., Layek B., Singh J. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. Int. J. Mol. Sci. 2022;23:1851. doi: 10.3390/ijms23031851. - DOI - PMC - PubMed
    1. Taylor J.J., Williams N.R., George M.S. Beyond Neural Cubism: Promoting a Multidimensional View of Brain Disorders by Enhancing the Integration of Neurology and Psychiatry in Education. Acad. Med. 2015;90:581–586. doi: 10.1097/ACM.0000000000000530. - DOI - PMC - PubMed

MeSH terms